3, 5, 7). The present study was performed in ,the isolated perfused dog lung in order to better quantitate absorption of albumin from the lung in a closed system, and to determine if absorption takes place in the absence of functioning pulmonary lymphatics.
The experiments were designed to study the absorption into the pulmonary perfusion blood of iodinated (1131) albumin introduced directly into the alveoli of the isolated dog lung. The quantity of tagged albumin absorbed directly into the pulmonary venous blood could be determined, since the pulmonary lymphatic system was interrupted in the preparation of the isolated perfused lungs.
METHODS
The isolated lungs were prepared by a modification of the technique described by Donald (4). Dogs weighing [15] [16] [17] [18] [19] [20] kg were anesthetized with sodium pentobarbital (30 mg iv/kg). An intratracheal cannulawasconnected to a respirator (Medrep respirator, Medical Research Products, Minneapolis), and the lungs ventilated throughout the period of the experiment with a mixture of g5 % oxygen-5 % carbon dioxide, at a rate of I 8 respirations per minute. Inspiratory pressure was maintained at 8-10 cm water and tidal volume at 300-400 ml. During the expiratory phase, tracheal pressure fell to zero (atmospheric pressure). Heparin (2.75 mg/kg) was injected intravenously and the animal exsanguinated through a carotid artery cannula. The thorax was entered through a midline incision, and a stainless steel cannula tied into place in the pulmonary artery. A flat-head (2.5 cm diam), multiple-orifice (4 mm) stainless steel cannula was introduced through the mitral valve into the left atrium and fixed in place by a ligature around the atrioventricular groove. All other vessels leading to and from the heart were tied off with ligatures.
The pulmonary artery cannula was filled with heparinized blood and connected to the perfusion system. The outflow from the left atria1 cannula was collected into a graduated glass reservoir, immersed in a water bath kept at 38 C. A polyethylene catheter, 2 mm in diameter, was passed through the tracheal cannula into a lower lobe bronchus to the point at which resistance was encountered.
Thirtyfive microcuries of iodinated (1131) albumin (RISA-6703, Abbott Laboratories, Oak Ridge, Tenn.) in 12 ml normal saline solution were gently instilled directly into the pulmonary alveoli through the intrabronchial catheter. The catheter was flushed with an additional 5 ml normal saline and removed.
The iodinated albumin solution contained approximately 3 mg human serum albumin per 35-PC dose and less than 2 70 radioactivity as loosely bound iodide-I 131. Serial-perfusion blood samples were obtained through a two-way stopcock connected to the left atria1 cannula.
Plasma radioactivity measurements were made in a scintillation-well counter (Tracerlab, model SC-57A). Total and protein-bound radioactivity in the plasma were measured.
Protein-bound 1131 was separated from free (iodide) 1131 by passage through an Amberlite resin column using a method described previously (IO). The perfusion blood volume was determined by measuring I accurately the volume of blood added to the empty system at the beginning of the perfusion, and that used to fill the arterial cannula. The volume was checked by adding a known volume of saline solution at the end of the perfusion period and determining the change in hemoglobin concentration.
The constancy of the perfusion volume during each experiment was established by repeated readings of the blood level in the graduated blood reservoir. Radioactivity absorbed into the perfusion plasma was expressed as the percent of the iodinated albumin dose instilled into the lung. None of the lung preparations exhibited signs of pulmonary edema during the period of observation or on examination at the end of each experiment.
In two experiments, chromatographic analysis of the perfusion plasma was made, after instillation of iodinated albumin into the lung. Perfusion blood samples were collected at I, 2, 3, and 4 hr after instillation of the tagged albumin into the isolated lung. Chromatography was also performed on a perfusion plasma sample to which iodinated albumin was added directly, and used as the reference standard. Chromatography was carried out on a diethylaminoethyl (DEAE)-cellulose column, I 2 mm OD and 350 mm high, equipped with a cooling water jacket at 5 C. The plasma (2 ml) was dialyzed against and exceeded the concentration of radioactivity attained in isolated lung perfusion blood.
RESULTS
Mean values for absorption of radioactivity from iodinated albumin solutions in eight lung perfusion studies are given in Table I and illustrated in Fig. I Table 3 . There was a gradual increase in protein-bound radioactivity with duration of incubation; however, at 6 hr only 0.20% and at 24 hr only 0.55 % of the iodide-1131 dose was protein bound.
The absorbance readings and radioactivity measurements on the chromatographic fractions from plasma are plotted in Fig. 2 and 88 with a peak at fraction 60, and closely approximates the albumin absorbance peak which occurs at about these same fractions. After instillation of iodinated albumin into the lung, there is a gradual increase of radioactivity in the plasma chromatographic fractions from the 1st to the 4th hr, with an increasing concentration between fractions 5 1-72, and the peak radioactivity at fraction 58. At 4 hr after instillation, the radioactivity curves of the chromatographed perfusion and reference plasmas are very similar. The only major difference is a small concentration of radioactivity at fraction 2 I, in the region of plasma globulin, which is not present in the reference plasma, and is much less than the main radioactivity concentration in the albumin region.
DISCUSSION
The character of the curves of plasma radioactivity concentrations absorbed from iodinated albumin solutions instilled into isolated dog lungs are very similar to those obtained in intact dogs (8). Both the total and the protein-bound radioactivity levels were higher in the perfused lung studies; however, the ratios of proteinbound to total plasma 1131 were lower than observed in the intact dog. These differences may be accounted for by the loss of radioactivity from the plasma into lymph and extracellular fluid after absorption in the intact dog, whereas losses did not occur from the closed perfusion system in the isolated lung experiments.
Iodide-1131 being readily diffusible from the vascular system will be lost in greater quantities than protein bound I131. However, as much as I o % of an iodinated albumin dose may disappear from the plasma during the 1st hr after intravenous injection, a considerable part of this appearing in thoracic duct lymph (9). A portion of the free 1131 appearing in the plasma reflects the rapid absorption of unbound 1131 present as iodide in the iodinated albumin solution introduced into the lung. The iodinated albumin solution used in these experiments contains less than 2 % radioactivity as iodide I 131; however, any iodide 1131 present in the albumin dose can be expected to be almost entirely absorbed from the lung within the 1st hr after instillation (8). This could account for the lower ratio of protein-bound to total radioactivity in the plasma during the 1st hr. The remainder of the plasma free 1131 is a result of the breakdown of iodinated albumin in the lung with release of I 131. The quantities of plasma free 1131 derived from each source cannot be calculated.
It can be concluded, however, that only a part of the observed concentration of free 1131 in the plasma can be attributed to breakdown of albumin in the lung with release of the 1131 label Previous studies (2, 3, 5, 7) have indicated little or no absorption of protein during the first 5 hr after introduction into the lung. Drinker and Hardenbergh (5) concluded that to clear the lung of plasma proteins it was 
